---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-25-000132"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:43:12.620750+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolent Q3 Adj EBITDA $39M (8.1% margin); new CFO Ramos; 2026 revenue forecast $2.5B

## Summary
- Q3 revenue $479.5M, net loss $26.9M; adjusted EBITDA $39.0M vs $31.8M YoY.
- Two new customer agreements bring YTD total to 13; >$750M new annualized revenue to launch in 2026.
- Mario Ramos appointed CFO effective Jan 1, 2026; John Johnson becomes Chief Strategy Officer.
- New CFO Ramos receives $550K base salary, $625K bonus, $100K sign-on bonus, and $2.35M RSU grant.
- Katie DiPerna named COO; Emily Rafferty transitions to EVP Customer Success.

## SEC filing metadata
- accession: 0001628908-25-000132
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890825000132/0001628908-25-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890825000132/evh-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-25-000132
- JSON: https://secwatch.observer/filing/0001628908-25-000132.json
- Plain text: https://secwatch.observer/filing/0001628908-25-000132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.